Autism Spectrum Disorder Treatment Market Size

Autism Spectrum Disorder Treatment Market size is evaluated at USD 36.2 billion in 2024 and is anticipated to reach USD 69.1 billion by the end of 2037, growing at around 5.1% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of autism spectrum disorder treatment is assessed at USD 38.05 billion.

The growing need for treatment services is primarily being driven by the rising prevalence of autism spectrum disorder worldwide. Rising numbers of cases have been detected as a result of increased awareness and improved diagnostic capabilities, which is driving up market expansion even more. People across the globe are steadily becoming aware of autism spectrum disorder (ASD), driving up demand for efficient treatment alternatives. For example, according to the statistics by Centers for Disease Control and Prevention (CDC), every 1 in 54 children in the U.S.  has is diagnosed with ASD which represents a significant increase in diagnostic rates over the previous ten years. Due to this, new treatment approaches have been developed, such as digital therapeutics, pharmacological treatments, and behavioral therapies, which have led to autism spectrum disorder treatment market expansion.

Advanced genetic testing, neuroimaging methods, and standardized screening instruments have improved healthcare providers' capacity to identify ASD early in the disorder's course. Early diagnosis is essential for prompt intervention, which can greatly enhance the quality of life and developmental outcomes for people with ASD, driving market expansion.